Yubao Lu

1.5k total citations · 3 hit papers
31 papers, 1.0k citations indexed

About

Yubao Lu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Yubao Lu has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 7 papers in Cancer Research. Recurrent topics in Yubao Lu's work include Spinal Cord Injury Research (7 papers), MicroRNA in disease regulation (6 papers) and Mesenchymal stem cell research (5 papers). Yubao Lu is often cited by papers focused on Spinal Cord Injury Research (7 papers), MicroRNA in disease regulation (6 papers) and Mesenchymal stem cell research (5 papers). Yubao Lu collaborates with scholars based in China, Germany and United States. Yubao Lu's co-authors include Zhanjun Ma, Xuexi Wang, Jingjing Yang, Ian T. Ferguson, Zhaoyang Liu, Shixin Wang, Xuewen Kang, Yujun Song, Yonggang Wang and Guohu Chen and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Molecular Psychiatry.

In The Last Decade

Yubao Lu

30 papers receiving 999 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine

2020 78 citations Shixin Wang, Yan Wang et al. Journal of Integrative Medicine profile →
Global incidence and characteristics of spinal cord injury since 2000–2021: a systematic review and meta-analysis

2024 49 citations Yubao Lu, Zhizhong Shang et al. BMC Medicine profile →
Global, regional, and national burden of spinal cord injury from 1990 to 2021 and projections for 2050: A systematic analysis for the Global Burden of Disease 2021 study

2024 40 citations Yubao Lu, Zhizhong Shang et al. Ageing Research Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yubao Lu China	17	279	155	144	129	113	31	1.0k
Tiantian Zhu China	22	353 1.3×	103 0.7×	173 1.2×	103 0.8×	42 0.4×	86	1.3k
Xianzhen Yin China	21	271 1.0×	90 0.6×	66 0.5×	182 1.4×	48 0.4×	74	1.3k
Dong Jun Park South Korea	19	349 1.3×	128 0.8×	57 0.4×	397 3.1×	141 1.2×	86	1.5k
I‐Chun Chen Taiwan	23	415 1.5×	135 0.9×	269 1.9×	247 1.9×	42 0.4×	104	1.9k
Lingjie Wang China	20	232 0.8×	86 0.6×	61 0.4×	372 2.9×	67 0.6×	107	1.3k
Qin Jin China	25	569 2.0×	106 0.7×	187 1.3×	128 1.0×	28 0.2×	81	1.5k
Wei Du China	20	257 0.9×	328 2.1×	85 0.6×	122 0.9×	62 0.5×	125	1.9k
Xiaoli Chen China	18	251 0.9×	44 0.3×	129 0.9×	120 0.9×	33 0.3×	58	1.1k
Yasuhiko Koga Japan	22	578 2.1×	71 0.5×	93 0.6×	93 0.7×	35 0.3×	91	1.5k
Bo Ning China	19	555 2.0×	71 0.5×	122 0.8×	434 3.4×	130 1.2×	109	2.0k

Countries citing papers authored by Yubao Lu

Since Specialization

Citations

This map shows the geographic impact of Yubao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yubao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yubao Lu more than expected).

Fields of papers citing papers by Yubao Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yubao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yubao Lu. The network helps show where Yubao Lu may publish in the future.

Co-authorship network of co-authors of Yubao Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yubao Lu. A scholar is included among the top collaborators of Yubao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yubao Lu. Yubao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Lu, Yubao Lu, Jia Liu, et al.. (2025). Targeting astrocytic CLC2(CLCN2) restores myelin regeneration through inhibition of SPP1/CD44 signaling pathway in leukoencephalopathy. Molecular Psychiatry. 31(1). 116–136.

Lu, Yubao, Zhizhong Shang, Wei Zhang, et al.. (2024). Global incidence and characteristics of spinal cord injury since 2000–2021: a systematic review and meta-analysis. BMC Medicine. 22(1). 285–285. 49 indexed citations breakdown →

Lu, Yubao, Zhizhong Shang, Wei Zhang, et al.. (2024). Global, regional, and national burden of spinal cord injury from 1990 to 2021 and projections for 2050: A systematic analysis for the Global Burden of Disease 2021 study. Ageing Research Reviews. 103. 102598–102598. 40 indexed citations breakdown →

Lu, Yubao, Jiayi Shen, Siying Qin, et al.. (2023). SCAN: Spatiotemporal Cloud Atlas for Neural cells. Nucleic Acids Research. 52(D1). D998–D1009. 3 indexed citations

Lu, Yubao, Wei Zhang, Zhenming Tian, et al.. (2022). The optimal transplantation strategy of umbilical cord mesenchymal stem cells in spinal cord injury: a systematic review and network meta-analysis based on animal studies. Stem Cell Research & Therapy. 13(1). 441–441. 9 indexed citations

Lu, Yubao, et al.. (2022). Novel Immunotherapies for Osteosarcoma. Frontiers in Oncology. 12. 830546–830546. 45 indexed citations

Tang, Chao, et al.. (2022). Molecular mechanism of microRNAs regulating apoptosis in osteosarcoma. Molecular Biology Reports. 49(7). 6945–6956. 6 indexed citations

Wang, Xuexi, Shixin Wang, Yubao Lu, et al.. (2022). Graphene and graphene-based materials in axonal repair of spinal cord injury. Neural Regeneration Research. 17(10). 2117–2117. 20 indexed citations

Chang, Xingyu, et al.. (2021). New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma. Journal of bone oncology. 29. 100372–100372. 54 indexed citations

10.

Lu, Yubao, et al.. (2021). Myeloperoxidase: a new target for the treatment of stroke?. Neural Regeneration Research. 17(8). 1711–1711. 22 indexed citations

11.

Zhang, Ruihao, et al.. (2021). Calcitonin gene-related peptide and brain-derived serotonin are related to bone loss in ovariectomized rats. Brain Research Bulletin. 176. 85–92. 12 indexed citations

12.

Wang, Shixin, Yan Wang, Yubao Lu, et al.. (2020). Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine. Journal of Integrative Medicine. 18(4). 275–283. 78 indexed citations breakdown →

13.

Ma, Zhanjun, Yubao Lu, Fengguang Yang, et al.. (2020). Rosmarinic acid exerts a neuroprotective effect on spinal cord injury by suppressing oxidative stress and inflammation via modulating the Nrf2/HO-1 and TLR4/NF-κB pathways. Toxicology and Applied Pharmacology. 397. 115014–115014. 74 indexed citations

14.

Ma, Zhanjun, Jingjing Yang, Yubao Lu, Zhaoyang Liu, & Xuexi Wang. (2020). Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine. World Journal of Stem Cells. 12(8). 814–840. 84 indexed citations

15.

Lu, Yubao, Jingjing Yang, Xuexi Wang, et al.. (2020). Research progress in use of traditional Chinese medicine for treatment of spinal cord injury. Biomedicine & Pharmacotherapy. 127. 110136–110136. 46 indexed citations

16.

Ma, Zhanjun, Jingjing Yang, Yang Yang, et al.. (2020). Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway. Phytomedicine. 68. 153186–153186. 59 indexed citations

17.

Hu, Xuchang, et al.. (2020). Progress in clinical trials of cell transplantation for the treatment of spinal cord injury: how many questions remain unanswered?. Neural Regeneration Research. 16(3). 405–405. 37 indexed citations

18.

Lü, Li, Guohu Chen, Jingjing Yang, et al.. (2019). Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K/AKT signaling pathway. Biomedicine & Pharmacotherapy. 112. 108625–108625. 56 indexed citations

19.

He, Mi, Yubao Lu, Lei Zhang, et al.. (2016). Combining Amplitude Spectrum Area with Previous Shock Information Using Neural Networks Improves Prediction Performance of Defibrillation Outcome for Subsequent Shocks in Out-Of-Hospital Cardiac Arrest Patients. PLoS ONE. 11(2). e0149115–e0149115. 25 indexed citations

20.

Ferguson, Ian T., et al.. (1998). Materials Science Forum. Materials science forum. 264–268. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact